S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
Critical asset just had biggest fall on record (Ad)
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Sports analytics may be outnumbered when it comes to artificial intelligence
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
South Korean doctors hold massive anti-government rally over medical school recruitment plan
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
What to watch for as China's major political meeting of the year gets underway
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
Critical asset just had biggest fall on record (Ad)
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Sports analytics may be outnumbered when it comes to artificial intelligence
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
South Korean doctors hold massive anti-government rally over medical school recruitment plan
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
What to watch for as China's major political meeting of the year gets underway
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
Critical asset just had biggest fall on record (Ad)
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Sports analytics may be outnumbered when it comes to artificial intelligence
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
South Korean doctors hold massive anti-government rally over medical school recruitment plan
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
What to watch for as China's major political meeting of the year gets underway
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
Critical asset just had biggest fall on record (Ad)
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Sports analytics may be outnumbered when it comes to artificial intelligence
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
South Korean doctors hold massive anti-government rally over medical school recruitment plan
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
What to watch for as China's major political meeting of the year gets underway
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case

Neurocrine Biosciences (NBIX) News Today

$131.30
+0.90 (+0.69%)
(As of 03/1/2024 ET)
SourceHeadline
marketbeat.com logoCaisse DE Depot ET Placement DU Quebec Reduces Position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
marketbeat.com - March 3 at 8:29 AM
MarketBeat logoLeslie V. Norwalk Sells 8,000 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Stock
americanbankingnews.com - March 2 at 4:44 AM
MarketBeat logoNeurocrine Biosciences (NASDAQ:NBIX) and Alvotech (NYSE:ALVO) Head-To-Head Analysis
americanbankingnews.com - March 2 at 1:46 AM
marketbeat.com logoBraidwell LP Has $108.90 Million Stock Position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
marketbeat.com - March 1 at 10:17 AM
finance.yahoo.com logoNeurocrine Biosciences Inc's Chief Regulatory Officer Ingrid Delaet Sells Company Shares
finance.yahoo.com - March 1 at 2:10 AM
marketbeat.com logoSoros Fund Management LLC Takes $6.19 Million Position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
marketbeat.com - February 28 at 4:47 PM
marketbeat.com logoAvidity Partners Management LP Has $73.36 Million Holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
marketbeat.com - February 27 at 4:24 PM
prnewswire.com logoNeurocrine Biosciences to Participate at Investor Conferences in March
prnewswire.com - February 27 at 4:01 PM
marketbeat.com logoWestfield Capital Management Co. LP Acquires 273,952 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
marketbeat.com - February 26 at 11:39 AM
finance.yahoo.com logoNBIX Dec 2024 200.000 call
finance.yahoo.com - February 25 at 2:20 PM
marketbeat.com logoConnor Clark & Lunn Investment Management Ltd. Has $7.88 Million Holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
marketbeat.com - February 25 at 7:59 AM
MarketBeat logoRichard F. Pops Sells 15,000 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Stock
americanbankingnews.com - February 25 at 5:32 AM
MarketBeat logoJPMorgan Chase & Co. Cuts Neurocrine Biosciences (NASDAQ:NBIX) Price Target to $148.00
americanbankingnews.com - February 25 at 4:00 AM
MarketBeat logoNeurocrine Biosciences, Inc. (NASDAQ:NBIX) Given Average Recommendation of "Moderate Buy" by Brokerages
americanbankingnews.com - February 25 at 1:36 AM
marketbeat.com logoNeurocrine Biosciences, Inc. (NASDAQ:NBIX) Shares Purchased by Acadian Asset Management LLC
marketbeat.com - February 24 at 6:45 AM
msn.com logoNeurocrine Biosciences (NBIX) Price Target Increased by 7.78% to 152.22
msn.com - February 23 at 10:13 PM
marketbeat.com logoJPMorgan Chase & Co. Trims Neurocrine Biosciences (NASDAQ:NBIX) Target Price to $148.00
marketbeat.com - February 23 at 1:34 PM
finance.yahoo.com logoDirector Richard Pops Sells 15,000 Shares of Neurocrine Biosciences Inc
finance.yahoo.com - February 23 at 7:12 AM
marketbeat.com logoNordea Investment Management AB Buys 19,238 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
marketbeat.com - February 23 at 6:30 AM
markets.businessinsider.com logoCritical Insights From Arcus Biosciences Analyst Ratings: What You Need To Know
markets.businessinsider.com - February 22 at 1:01 PM
marketbeat.com logoOntario Teachers Pension Plan Board Makes New Investment in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
marketbeat.com - February 22 at 9:26 AM
marketbeat.com logoQRG Capital Management Inc. Makes New Investment in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
marketbeat.com - February 21 at 6:52 AM
marketbeat.com logoAviva PLC Invests $1.66 Million in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
marketbeat.com - February 20 at 6:44 AM
marketbeat.com logoNeurocrine Biosciences, Inc. (NASDAQ:NBIX) Shares Sold by PAX Financial Group LLC
marketbeat.com - February 19 at 10:18 AM
marketbeat.com logoRafferty Asset Management LLC Has $9.17 Million Stock Position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
marketbeat.com - February 18 at 7:28 AM
finance.yahoo.com logoNBIX Mar 2024 120.000 call
finance.yahoo.com - February 17 at 6:48 PM
finance.yahoo.com logoNBIX Mar 2024 140.000 put
finance.yahoo.com - February 17 at 6:48 PM
ca.finance.yahoo.com logoNBIX Mar 2024 110.000 call
ca.finance.yahoo.com - February 17 at 8:47 AM
marketbeat.com logoLoomis Sayles & Co. L P Has $28.90 Million Stock Holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
marketbeat.com - February 16 at 7:59 AM
marketbeat.com logoRhenman & Partners Asset Management AB Increases Position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
marketbeat.com - February 15 at 7:43 PM
benzinga.com logoCHARLES KEVIN GORMAN At Neurocrine Biosciences Decides to Exercises Options Worth $470K
benzinga.com - February 15 at 1:14 PM
marketbeat.com logo54,000 Shares in Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Bought by Atika Capital Management LLC
marketbeat.com - February 14 at 4:31 PM
marketbeat.com logoNeurocrine Biosciences (NASDAQ:NBIX) Stock Price Up 2.8%
marketbeat.com - February 13 at 1:31 PM
markets.businessinsider.com logoPositive Outlook for Neurocrine Biosciences with Underappreciated Pipeline Potential
markets.businessinsider.com - February 13 at 12:58 PM
marketbeat.com logoNeurocrine Biosciences, Inc. (NASDAQ:NBIX) Short Interest Down 18.6% in January
marketbeat.com - February 13 at 11:27 AM
marketbeat.com logoNeurocrine Biosciences, Inc. (NASDAQ:NBIX) Shares Acquired by Fiera Capital Corp
marketbeat.com - February 13 at 11:10 AM
marketbeat.com logoNeurocrine Biosciences, Inc. (NASDAQ:NBIX) Shares Sold by Marsico Capital Management LLC
marketbeat.com - February 12 at 12:47 PM
marketbeat.com logoFY2024 Earnings Forecast for Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Issued By Cantor Fitzgerald
marketbeat.com - February 12 at 2:40 AM
marketbeat.com logoAndra AP fonden Reduces Stock Position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
marketbeat.com - February 10 at 10:17 AM
finance.yahoo.com logoDecoding Neurocrine Biosciences Inc (NBIX): A Strategic SWOT Insight
finance.yahoo.com - February 10 at 12:50 AM
marketbeat.com logoScout Investments Inc. Boosts Stock Holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
marketbeat.com - February 9 at 7:23 PM
finance.yahoo.com logoNeurocrine Biosciences Inc's Chief Commercial Officer Eric Benevich Sells Company Shares
finance.yahoo.com - February 9 at 9:48 AM
finance.yahoo.com logoNeurocrine Biosciences Full Year 2023 Earnings: EPS Beats Expectations
finance.yahoo.com - February 9 at 9:48 AM
markets.businessinsider.com logoPromising Pipeline and Market Positioning Underpin Buy Rating for Neurocrine’s Stock (NBIX)
markets.businessinsider.com - February 9 at 12:30 AM
marketbeat.com logoNeurocrine Biosciences (NASDAQ:NBIX) Releases Quarterly Earnings Results, Beats Expectations By $0.31 EPS
marketbeat.com - February 8 at 12:59 PM
marketbeat.com logoNeurocrine Biosciences (NASDAQ:NBIX) Price Target Lowered to $140.00 at Citigroup
marketbeat.com - February 8 at 11:53 AM
marketbeat.com logoMizuho Raises Neurocrine Biosciences (NASDAQ:NBIX) Price Target to $140.00
marketbeat.com - February 8 at 11:00 AM
markets.businessinsider.com logoBreaking Down Neurocrine Biosciences: 8 Analysts Share Their Views
markets.businessinsider.com - February 8 at 9:29 AM
finance.yahoo.com logoNeurocrine Biosciences, Inc. (NASDAQ:NBIX) Q4 2023 Earnings Call Transcript
finance.yahoo.com - February 8 at 9:29 AM
markets.businessinsider.com logoNeurocrine Biosciences Buy Rating Affirmed Amid Solid Ingrezza Growth and Promising Pipeline
markets.businessinsider.com - February 7 at 11:26 PM
Get Neurocrine Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for NBIX and its competitors with MarketBeat's FREE daily newsletter.



NBIX Media Mentions By Week

NBIX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

NBIX
News Sentiment

0.63

0.64

Average
Medical
News Sentiment

NBIX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

NBIX Articles
This Week

14

7

NBIX Articles
Average Week

Get Neurocrine Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for NBIX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:NBIX) was last updated on 3/3/2024 by MarketBeat.com Staff